Do you remember when friends prodded you to either dump a bucket of ice water over your head or make a donation to the ALS association? That activity went viral in 2014, raising more than $220 million to fight what's also called Lou Gehrig's disease. Eight years later, the funds have contributed to the creation of a new drug. In September, the FDA approved Relyvrio, the third U.S.-approved medicine for ALS, though it's not without controversy. Learn more about it and the drug pricing debate.
Photo: image.cnbcfm.com
The Food and Drug Administration on Thursday approved a new drug to slow the progression of ALS, a fatal neurodegenerative disease for which there is no cure. The drug, made by Amylyx Pharmaceuticals, joins a handful of approved medications for the fatal neurodegenerative disease. The Food and Drug …
Remember the "Ice Bucket Challenge" in 2014? All around the world, people were dumping buckets full of ice water on their heads and committing to …
Also, it costs how much!? The Food and Drug Administration (FDA) has approved a new drug to treat amyotrophic lateral sclerosis (ALS)—and it’s …
The FDA's expedited approval of a new ALS treatment priced at $158,000 a year, has touched off another debate over balancing regulation with patient …
When Nancy Frates heard that the US Food and Drug Administration had approved a promising new drug for ALS — the fatal motor neuron disease that took …
One year ago, icy water inundated the Internet in what may have been the online equivalent of the largest chain letter ever—the ALS Ice Bucket …
